Exchange: NASDAQ·Updated 07:55 PM EDT
ALMS logo

ALMS Alumis Inc.

$22.38
$0.83
(3.58%)
Today
Closed $22.38
$0.19
(0.85%)
After Hours
Reported EarningsAug 13
Mkt Cap$2.99B
Vol655,336.00

About ALMS

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
38

Bearish Sentiment

How do you feel about ALMS?

Advertisement|Remove ads.